AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Unprecedented survival results with combination oral Xeloda and Taxotere.(metastatic breast cancer)(Brief Article)
2002 JUL 18 - (NewsRx.com & NewsRx.net) -- The authors of a publication in the Journal of Clinical Oncology (2002;20(12):2812-2823) conclude that a study of over 500 women with metastatic breast cancer demonstrates that the combination of Xeloda (capecitabine) tablets and intravenous Taxotere (docetaxel) is far more effective than Taxotere chemotherapy alone, resulting in the women on the combination therapy living an average of 3 months longer. This is an unprecedented outcome in this patient group.
"The study results confirm that Xeloda is a powerful breast cancer treatment that can change the natural history of advanced breast cancer," said Dr. Joyce O'Shaughnessy, of U.S. Oncology, Inc., codirector of breast cancer research at Baylor-Sammons Cancer Center, Texas, USA, and lead investigator of the study. "Xeloda, combined with Taxotere, is an important treatment improvement and represents a major advance in the management of women with metastatic breast cancer. This combination therapy provides new hope for women with breast cancer and their families."
The Xeloda/Taxotere combination ...
- CAELYX(R) Delays Time to Disease Progression as Maintenance Therapy in Patients...
- Press release article from: PR Newswire June 3, 2007 700+ words
...TTP) in patients with metastatic breast cancer with infrequent and manageable...effective for patients with metastatic breast cancer, their response is short...the 288 patients with metastatic breast cancer registered for the trial...
- Metastatic disease is relatively common in cases of breast cancer.(Metastatic...
- Magazine article from: CME: Your SA Journal of CPD Gudgeon, Anne October 1, 2008 700+ words
...drugs for the treatment of metastatic breast cancer will soon be registered...palliative care. Treatment of metastatic breast cancer is given on an individual...care. In a nutshell * Metastatic breast cancer treatment is not curative...
- Video: Cities and States Around the U.S. Recognize October 13 as Metastatic...
- Press release article from: PR Newswire October 13, 2009 700+ words
...Recognize the Underrepresented Metastatic Breast Cancer Community NEW YORK, Oct...experiences of those living with metastatic breast cancer (MBC), the most advanced...advocates nationwide and the Metastatic Breast Cancer Network, United States...
- CAELYX Demonstrates Efficacy and Reduced Cardiac Toxicity in First-Line...
- Press release article from: PR Newswire March 11, 2004 700+ words
...first-line treatment of metastatic breast cancer with significantly reduced...CAELYX in the treatment of metastatic breast cancer represent an important...monotherapy for the treatment of metastatic breast cancer in women who are at cardiac...
- Schering-Plough Announces EU Approval of CAELYX(R) in Metastatic Breast Cancer.
- Press release article from: PR Newswire January 14, 2003 700+ words
...hydrochloride) as monotherapy for metastatic breast cancer in patients who are at...active agents used to treat metastatic breast cancer. Additionally, CAELYX...with end-stage, or metastatic breast cancer, five-year survival...
- CAELYX and Herceptin Combination Shows Activity With Limited Cardiotoxicity in...
- Press release article from: PR Newswire June 5, 2004 700+ words
...HER-2 positive(1) metastatic breast cancer (MBC). Findings from...active agents for treating metastatic breast cancer, combining an anthracycline...with end-stage, or metastatic breast cancer, five-year survival...
- Schering-Plough Reports European Union's CPMP Recommends Approval of CAELYX(R)...
- Press release article from: PR Newswire October 18, 2002 700+ words
...hydrochloride) as monotherapy for metastatic breast cancer in patients who are at...active agents used to treat metastatic breast cancer. Additionally, CAELYX...with end-stage, or metastatic breast cancer, five-year survival...
- FDA Grants Approval for Lilly's Gemzar(R) in Combination with Taxol(R) as...
- Press release article from: PR Newswire May 19, 2004 700+ words
...therapy for women battling metastatic breast cancer. The FDA's approval...Patients diagnosed with metastatic breast cancer and treated with a combination...treatment of patients with metastatic breast cancer after failure of prior...
Source: HighBeam Research, Unprecedented survival results with combination oral Xeloda and...